ONECUT2
Basic information
Region (hg38): 18:57435374-57491298
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ONECUT2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 26 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 2 | 2 |
Variants in ONECUT2
This is a list of pathogenic ClinVar variants found in the ONECUT2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-57435735-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
18-57435774-A-G | not specified | Uncertain significance (Oct 22, 2021) | ||
18-57435775-T-C | not specified | Uncertain significance (Mar 30, 2022) | ||
18-57435781-C-G | not specified | Uncertain significance (Nov 21, 2022) | ||
18-57435816-G-T | not specified | Uncertain significance (May 16, 2022) | ||
18-57435831-G-T | not specified | Uncertain significance (Nov 13, 2023) | ||
18-57435832-G-A | not specified | Uncertain significance (Nov 09, 2023) | ||
18-57435846-G-A | not specified | Likely benign (Aug 17, 2022) | ||
18-57435860-C-G | Likely benign (Feb 01, 2023) | |||
18-57435877-G-T | not specified | Uncertain significance (Oct 05, 2023) | ||
18-57435886-A-G | not specified | Uncertain significance (Feb 27, 2024) | ||
18-57435890-G-T | not specified | Uncertain significance (Apr 07, 2023) | ||
18-57435894-G-A | not specified | Uncertain significance (May 27, 2022) | ||
18-57435934-G-T | not specified | Uncertain significance (May 23, 2023) | ||
18-57435951-C-T | not specified | Uncertain significance (Dec 06, 2023) | ||
18-57435991-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
18-57436076-G-A | Benign (Apr 20, 2018) | |||
18-57436207-C-G | Autosomal dominant polycystic liver disease • not specified | Uncertain significance (Apr 08, 2024) | ||
18-57436268-C-G | not specified | Uncertain significance (Nov 08, 2022) | ||
18-57436287-G-A | not specified | Uncertain significance (Nov 28, 2023) | ||
18-57436293-G-A | not specified | Uncertain significance (Nov 12, 2021) | ||
18-57436319-G-T | not specified | Uncertain significance (Oct 26, 2022) | ||
18-57436354-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
18-57436392-C-G | Autosomal dominant polycystic liver disease | Uncertain significance (Sep 01, 2021) | ||
18-57436398-G-A | not specified | Uncertain significance (Apr 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ONECUT2 | protein_coding | protein_coding | ENST00000491143 | 2 | 55613 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.907 | 0.0929 | 124347 | 0 | 1 | 124348 | 0.00000402 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.32 | 219 | 281 | 0.779 | 0.0000147 | 3248 |
Missense in Polyphen | 87 | 111.01 | 0.7837 | 1150 | ||
Synonymous | -1.02 | 133 | 119 | 1.12 | 0.00000608 | 1058 |
Loss of Function | 2.95 | 1 | 12.1 | 0.0830 | 6.06e-7 | 127 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000888 | 0.00000888 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional activator. Activates the transcription of a number of liver genes such as HNF3B.;
Recessive Scores
- pRec
- 0.184
Intolerance Scores
- loftool
- 0.0369
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 17.75
Haploinsufficiency Scores
- pHI
- 0.118
- hipred
- Y
- hipred_score
- 0.800
- ghis
- 0.536
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.991
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Onecut2
- Phenotype
- liver/biliary system phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- liver development;regulation of cell-matrix adhesion;epithelial cell development;animal organ morphogenesis;cell differentiation;positive regulation of cell migration;negative regulation of transforming growth factor beta receptor signaling pathway;endocrine pancreas development;cell fate commitment;positive regulation of transcription by RNA polymerase II;peripheral nervous system neuron development;cilium assembly
- Cellular component
- nucleus;nucleoplasm;actin cytoskeleton
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding